Vericel Corp (NAS:VCEL)
$ 51.53 0.4 (0.78%) Market Cap: 2.50 Bil Enterprise Value: 2.47 Bil PE Ratio: 9,999.00 PB Ratio: 10.69 GF Score: 79/100

Vericel Corp at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 13, 2021 / 01:00PM GMT
Release Date Price: $53.57 (-0.67%)
Jeff Cohen
Ladenburg Thalmann & Co. Inc. - Analyst

Good morning, this is Jeff Cohen and Destiny Hance from Ladenburg Thalmann. With us presenting is Nick Colangelo from Vericel. Nick is the CEO, President and Director. We're excited to have him on and he's going to go about half the time through some slides and we're going to open it up for some Q&A. Thank you, Nick.

Nick Colangelo
Vericel Corporation - President & CEO

Well, hey, thanks, Jeff. Good to be here. And as always, before I begin, just want to remind folks that this presentation contains forward-looking statements, and you should refer to our documents on file with the SEC for further information. Jeff, as we talked about, I'll try to hit the highlights so we can save some time for questions at the end.

And so, for those who are not as familiar with Vericel, we're a leader in advanced therapies for the sports medicine and severe burn cure market. We have a portfolio of innovative cell therapies and specialty biologics with a unique defining feature of the Company that we have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot